Grant advisory

BioM consults small and medium-sized biotechnological companies in financing research and development projects by public funding.

Promotion Programs for Small and Medium-Sized Enterprises

Bavaria

BayTP+ is a technology promotion program providing support for small and medium-sized enterprises in developing new products or production processes.

Bavarian Research Foundation - grants for research and development projects in alliances

National Funding Oppotunities

With KMU-innovativ: Biomedicine, the BMBF strengthens the innovative power of SMEs in medical biotechnology. Funding is provided for research and development projects (R&D projects) in the field of medical biotechnology that focus on the area of drug development and go beyond the state of the art.

ZIM - Central Innovation Program for Medium-sized Enterprises (Zentrales Innovationsprogramm Mittelstand) is a funding program for small and medium-sized enterprises and research institutes collaborating with companies that is targeting technological and industrial purposes.

Internationale Supporting Measures

Eurostars - Support program for small and medium-sized enterprises (SMEs) to carry out research and development projects, jointly with partners in other member states, within the framework of the European research initiative EUREKA

Within the scope of Horizon Europe, the EU commission addresses social challenges like health and demographic changes.

the European EIC Accelerator promotes the development of innovations in small and medium-size enterprises (SME).

The Bavarian Research Alliance and the National Contact Point for Life Sciences assist in applying for EU programs.

EIT Health Germany, the German Co-Location Center of EIT Health, provides support, skills and services for startups and SMEs to boost their business idea.


More about this topic

Biotech in Bavaria: Record investments and stable development

BioM pub­lishes an­nu­al re­port “Bi­otech in Bav­aria 2024/25” Re­cord fin­an­cing of over 910 mil­lion eurosS­light in­crease to 540…

BayOConnect 2025 – Preview of Day 1: Global Perspectives, Strategic Alliances and Innovation in Focus

The count­down is on: On 1-2 July, Bay­oCon­nect 2025 will once again bring to­geth­er key stake­hold­ers from bi­otech, pharma, aca­demia,…

Daiichi Sankyo becomes “Golden Ticket” sponsor of the BioM biotech incubator MAxL

Found­ing teams can con­duct re­search at MAxL free of charge for one year The Japan­ese phar­ma­ceut­ic­al com­pany Daii­chi Sankyo has…
Dr. Max Pöhlmann
Dr. Max Pöhlmann

Cluster Development Lead